av/glaxosmithkline--big.svg

NYSE:GSK

GSK plc

  • Stock

USD

Last Close

1,783.50

17/05 10:24

Market Cap

628.30M

Beta: 0.28

Volume Today

1.73M

Avg: 3.25M

PE Ratio

11.06

PFCF: 21.23

Dividend Yield

4.19%

Payout:38.42%

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
5.63B
-
2.83B
49.70%
8.37B
195.73%
1.06B
87.31%
2.17B
104.24%
4.05B
86.54%
5.27B
30.20%
6.39B
21.26%
5.10B
20.23%
4.92B
3.43%
4.93B
0.14%
depreciation and amortization
1.42B
-
2.03B
43.18%
1.86B
8.09%
1.86B
0.05%
2.98B
60.18%
1.76B
40.86%
3.00B
69.94%
624M
79.17%
2.52B
304.49%
2.30B
8.95%
2.29B
0.17%
deferred income tax
-892M
-
-581M
34.87%
-8.71B
1,399.66%
2.61B
129.99%
1.50B
42.48%
1.78B
18.56%
-1.95B
209.65%
80M
104.09%
-318M
497.50%
-784M
146.54%
-865M
10.33%
stock based compensation
319M
-
332M
4.08%
368M
10.84%
319M
13.32%
333M
4.39%
360M
8.11%
365M
1.39%
381M
4.38%
367M
3.67%
346M
5.72%
307M
11.27%
change in working capital
46M
-
-91M
297.83%
27M
129.67%
-22M
181.48%
-737M
3,250%
-247M
66.49%
531M
314.98%
120M
77.40%
-473M
494.17%
271M
157.29%
-856M
415.87%
accounts receivables
-192M
-
-383M
99.48%
-1.16B
203.39%
-616M
46.99%
-649M
5.36%
inventory
-95M
-
-529M
456.84%
-111M
79.02%
70M
163.06%
-461M
758.57%
51M
111.06%
300M
488.24%
119M
60.33%
25M
78.99%
-269M
1,176%
-424M
57.62%
accounts payables
263M
-
225M
14.45%
229M
1.78%
494M
115.72%
-15M
103.04%
other working capital
141M
-
438M
210.64%
138M
68.49%
-92M
166.67%
-276M
200%
-298M
7.97%
160M
153.69%
159M
0.63%
435M
173.58%
662M
52.18%
232M
64.95%
other non cash items
706M
-
659M
6.66%
653M
0.91%
664M
1.68%
669M
0.75%
717M
7.17%
814M
13.53%
848M
4.18%
756M
10.85%
351M
53.57%
540M
53.85%
net cash provided by operating activities
7.22B
-
5.18B
28.33%
2.57B
50.37%
6.50B
152.90%
6.92B
6.48%
8.42B
21.73%
8.02B
4.76%
8.44B
5.25%
7.95B
5.79%
7.40B
6.90%
6.35B
14.25%
investments in property plant and equipment
-1.70B
-
-1.75B
2.94%
-1.90B
8.57%
-2.35B
23.72%
-2.20B
6.38%
-1.80B
18.44%
-2.16B
20.43%
-2.24B
3.51%
-2.93B
30.91%
-2.26B
22.96%
-2.34B
3.81%
acquisitions net
1.95B
-
235M
87.95%
7.53B
3,103.40%
592M
92.14%
356M
39.86%
-292M
182.02%
-3.78B
1,194.52%
3.01B
179.58%
185M
93.85%
-3.14B
1,795.14%
-1.38B
55.87%
purchases of investments
15M
-
1M
93.33%
-2M
300%
-928M
46,300%
4M
100.43%
-309M
7,825%
-258M
16.50%
-1M
99.61%
1.76B
176,000%
-144M
108.19%
-123M
14.58%
sales maturities of investments
59M
-
205M
247.46%
357M
74.15%
683M
91.32%
4M
99.41%
-452M
11,400%
1M
100.22%
3.27B
326,800%
18M
99.45%
1M
94.44%
1.91B
190,400%
other investing activites
200M
-
232M
16%
55M
76.29%
736M
1,238.18%
395M
46.33%
1.30B
228.10%
846M
34.72%
-1.88B
321.75%
-808M
56.93%
-3.23B
300.37%
12M
100.37%
net cash used for investing activites
524M
-
-1.08B
305.73%
6.04B
660.02%
-1.27B
121.02%
-1.44B
13.71%
-1.55B
7.62%
-5.35B
244.75%
2.16B
140.36%
-1.78B
182.23%
-8.77B
393.64%
-1.93B
77.95%
debt repayment
-1.87B
-
-1.71B
8.71%
-2.41B
41.14%
-919M
61.90%
-3.20B
248.20%
-1.99B
37.94%
-8.03B
304.23%
-7.30B
9.01%
-2.00B
72.69%
-4.62B
131.68%
-2.37B
48.72%
common stock issued
585M
-
167M
71.45%
73M
56.29%
89M
21.92%
56M
37.08%
74M
32.14%
51M
31.08%
29M
43.14%
21M
27.59%
25M
19.05%
10M
60%
common stock repurchased
-1.55B
-
-333M
78.50%
-99M
70.27%
-74M
25.25%
-65M
12.16%
8.77B
13,598.46%
10.28B
17.21%
999M
90.29%
-1.64B
264.46%
-197M
-
dividends paid
-3.68B
-
-3.84B
4.43%
-3.87B
0.81%
-4.85B
25.19%
-3.91B
19.46%
-3.93B
0.54%
-3.95B
0.66%
-3.98B
0.61%
-4.00B
0.55%
-3.47B
13.30%
-2.25B
35.19%
other financing activites
243M
-
333M
37.04%
-791M
337.54%
-638M
19.34%
735M
215.20%
-9.32B
1,368.57%
-194M
97.92%
122M
162.89%
27M
77.87%
8.89B
32,814.81%
-78M
100.88%
net cash used provided by financing activities
-6.27B
-
-5.38B
14.16%
-7.10B
31.90%
-6.39B
10.01%
-6.38B
0.19%
-6.39B
0.14%
-1.84B
71.20%
-10.13B
450.65%
-7.59B
25.10%
823M
110.84%
-4.88B
693.20%
effect of forex changes on cash
-148M
-
84M
156.76%
-45M
153.57%
283M
728.89%
-100M
135.34%
8M
108%
-82M
1,125%
-39M
52.44%
-29M
25.64%
152M
624.14%
-99M
165.13%
net change in cash
1.32B
-
-1.20B
190.79%
1.46B
221.20%
-881M
160.43%
-1.00B
14.07%
487M
148.46%
744M
52.77%
431M
42.07%
-1.44B
434.80%
-394M
72.70%
-787M
99.75%
cash at beginning of period
3.91B
-
5.23B
33.92%
4.03B
23.00%
5.49B
36.20%
4.61B
16.06%
3.60B
21.82%
4.09B
13.53%
4.83B
18.20%
5.26B
8.92%
3.82B
27.42%
3.72B
2.51%
cash at end of period
5.23B
-
4.03B
23.00%
5.49B
36.20%
4.61B
16.06%
3.60B
21.82%
4.09B
13.53%
4.83B
18.20%
5.26B
8.92%
3.82B
27.42%
3.42B
10.32%
2.94B
14.28%
operating cash flow
7.22B
-
5.18B
28.33%
2.57B
50.37%
6.50B
152.90%
6.92B
6.48%
8.42B
21.73%
8.02B
4.76%
8.44B
5.25%
7.95B
5.79%
7.40B
6.90%
6.35B
14.25%
capital expenditure
-1.70B
-
-1.75B
2.94%
-1.90B
8.57%
-2.35B
23.72%
-2.20B
6.38%
-1.80B
18.44%
-2.16B
20.43%
-2.24B
3.51%
-2.93B
30.91%
-2.26B
22.96%
-2.34B
3.81%
free cash flow
5.52B
-
3.42B
37.96%
668M
80.50%
4.14B
520.51%
4.72B
13.78%
6.63B
40.48%
5.86B
11.59%
6.20B
5.89%
5.02B
19.04%
5.14B
2.47%
4.00B
22.18%

All numbers in USD (except ratios and percentages)